Latest Revenue Guidance News

Aroa Biosurgery has reported FY25 results that exceed revenue guidance and deliver a positive normalised EBITDA, setting the stage for ambitious growth and reimbursement expansion in FY26.

Propel Funeral Partners has released its FY25 financial guidance projecting steady revenue growth despite temporary industry volume contraction, alongside announcing the upcoming retirement of its Managing Director and Co-Founder.

Credit Clear Limited confirms it remains on track to meet its FY25 earnings guidance, buoyed by strong client growth and cost-cutting measures, even as revenue forecasts are revised downward due to timing delays.

3P Learning forecasts steady revenue for FY25 but anticipates a significant 20% uplift in underlying EBITDA and a stronger net cash position, driven by strategic product expansions.

Duratec Limited has lowered its FY25 revenue and EBITDA guidance due to project delays and weather disruptions but remains optimistic about a robust pipeline and growth prospects in FY26.

SKS Technologies has delivered a robust first half in 2025, showcasing strong revenue growth and a burgeoning project pipeline, underpinned by zero debt and strategic expansion in data centres and traditional electrical services.

AVITA Medical reported a robust 67% increase in first quarter 2025 revenue, driven by new product launches and a strategic commercial overhaul, while reaffirming its full-year growth and profitability targets.

Chrysos Corporation reported a 25% year-on-year revenue increase in Q3 FY25, driven by strong growth in sample volumes and expanded deployment of its PhotonAssay technology across key mining regions.

Motio Limited has upgraded its FY25 financial guidance following robust trading after the April period, raising revenue and cash EBITDA targets while maintaining a solid cash position.

DXN Limited reported a modest 2% revenue increase to $2.5 million in Q3 FY25, launched its Data Centre as a Service division with a $3.6 million initial contract, and progressed a key acquisition valued at $10 million, positioning itself for growth despite some project delays.

Genesis Resources has completed its acquisition of full ownership of the Plavica JV in North Macedonia and is progressing environmental studies and exploration planning for multiple Australian tenements ahead of 2025 drilling campaigns.

Microba Life Sciences reported robust Q3 FY25 growth in its microbiome diagnostic tests, led by MetaXplore and MetaPanel, while advancing its therapeutics pipeline and projecting strong full-year revenue growth.